Literature DB >> 9048967

Detection of colorectal carcinoma cells in circulating peripheral blood by reverse transcription-polymerase chain reaction targeting cytokeratin-20 mRNA.

N O Funaki1, J Tanaka, A Itami, T Kasamatsu, G Ohshio, H Onodera, K Monden, T Okino, M Imamura.   

Abstract

For the detection of circulating colorectal carcinoma cells, we investigated the presence of cytokeratin 20 (CK 20) mRNA in the peripheral blood of colorectal carcinoma patients. Application of our published technique resulted in analysis by reverse transcription followed by three-step nested polymerase chain reaction. This analysis could detect a single Colo 205 colon cancer cell mixed with 1 ml of blood. Our system also successfully detected the presence of CK 20 mRNA in actual patients' peripheral blood samples. Our highly sensitive and specific system for the detection of CK-20 mRNA from patients' peripheral blood thus seems to be useful for screening for circulating colorectal carcinoma cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9048967     DOI: 10.1016/s0024-3205(96)00700-x

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  9 in total

1.  Disseminated single tumor cells as detected by real-time quantitative polymerase chain reaction represent a prognostic factor in patients undergoing surgery for colorectal cancer.

Authors:  Ulrich Guller; Paul Zajac; Annelies Schnider; Beatrix Bösch; Stefan Vorburger; Markus Zuber; Giulio Cesare Spagnoli; Daniel Oertli; Robert Maurer; Urs Metzger; Felix Harder; Michael Heberer; Walter Richard Marti
Journal:  Ann Surg       Date:  2002-12       Impact factor: 12.969

2.  Laparoscopic-assisted vs. open colectomy for colorectal cancer: influence on neoplastic cell mobilization.

Authors:  X Bessa; A Castells; A M Lacy; J I Elizalde; S Delgado; L Boix; V Piñol; M Pellisé; J C García-Valdecasas; J M Piqué
Journal:  J Gastrointest Surg       Date:  2001 Jan-Feb       Impact factor: 3.452

3.  Quantitative real-time RT-PCR detection for CEA, CK20 and CK19 mRNA in peripheral blood of colorectal cancer patients.

Authors:  Dong Xu; Xu-fen Li; Shu Zheng; Wen-zhi Jiang
Journal:  J Zhejiang Univ Sci B       Date:  2006-06       Impact factor: 3.066

4.  Hematogenous tumor cell dissemination during colonoscopy for colorectal cancer.

Authors:  M Koch; P Kienle; P Sauer; F Willeke; K Buhl; A Benner; T Lehnert; C Herfarth; M von Knebel Doeberitz; J Weitz
Journal:  Surg Endosc       Date:  2004-01-23       Impact factor: 4.584

5.  Impact of circulating free tumor cells in the peripheral blood of colorectal cancer patients during laparoscopic surgery.

Authors:  Wei-Shone Chen; Ming-Yi Chung; Jin-Hwang Liu; Jacqueline Ming Liu; Jen-Kou Lin
Journal:  World J Surg       Date:  2004-06       Impact factor: 3.352

6.  Cytokeratin 20 mRNA in peripheral venous blood of colorectal carcinoma patients.

Authors:  N O Funaki; J Tanaka; G Ohshio; H Onodera; S Maetani; M Imamura
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

7.  Limitations of CD44v6 amplification for the detection of tumour cells in the blood of colorectal cancer patients.

Authors:  D Masson; M G Denis; P Lustenberger
Journal:  Br J Cancer       Date:  2000-04       Impact factor: 7.640

8.  Detection of cytokeratins 19/20 and guanylyl cyclase C in peripheral blood of colorectal cancer patients.

Authors:  S A Bustin; V G Gyselman; N S Williams; S Dorudi
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

9.  Common molecular markers between circulating tumor cells and blood exosomes in colorectal cancer: a systematic and analytical review.

Authors:  Somayeh Vafaei; Fahimeh Fattahi; Marzieh Ebrahimi; Leila Janani; Ahmad Shariftabrizi; Zahra Madjd
Journal:  Cancer Manag Res       Date:  2019-09-25       Impact factor: 3.989

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.